Yanfang Guan Selected Research

CA-19-9 Antigen (CA 19-9 Antigen)

1/2016

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanfang Guan Research Topics

Disease

43	Neoplasms (Cancer) 01/2024 - 06/2013
12	Breast Neoplasms (Breast Cancer) 01/2022 - 10/2016
7	Lung Neoplasms (Lung Cancer) 12/2022 - 01/2019
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 01/2019
5	Hepatocellular Carcinoma (Hepatoma) 04/2020 - 01/2016
3	Stomach Neoplasms (Stomach Cancer) 11/2020 - 05/2019
3	Liver Neoplasms (Liver Cancer) 10/2020 - 08/2015
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2016
2	Triple Negative Breast Neoplasms 02/2021 - 12/2020
2	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2019
2	Carcinogenesis 01/2016 - 01/2011
1	Linitis Plastica 01/2023
1	Kidney Calculi (Kidney Stone) 01/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Gallstones (Gallstone) 01/2023
1	Chromosomal Instability (Chromosome Stability) 12/2022
1	Genomic Instability 10/2022
1	Multiple Myeloma 10/2022
1	Fever (Fevers) 01/2022
1	Exanthema (Rash) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2021
1	Ovarian Epithelial Carcinoma 01/2021
1	Leukemia 04/2020
1	Lymphatic Metastasis 03/2020
1	Adenocarcinoma of Lung 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Thrombosis (Thrombus) 01/2020
1	Liver Diseases (Liver Disease) 01/2018
1	Hemangioblastoma 01/2018
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Hepatitis B 01/2018
1	Chronic Hepatitis B 01/2018
1	Pheochromocytoma 01/2018
1	Hepatitis 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2018
1	Cushing Syndrome 12/2017
1	Osteoporosis 12/2017

Drug/Important Bio-Agent (IBA)

26	Circulating Tumor DNAIBA 10/2023 - 01/2016
16	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2013
13	Biomarkers (Surrogate Marker)IBA 10/2022 - 08/2015
5	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2020
4	Cell-Free Nucleic AcidsIBA 12/2022 - 01/2017
4	human ERBB2 proteinIBA 01/2022 - 05/2019
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2020
3	Indicators and Reagents (Reagents)IBA 02/2021 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2013
2	ErbB Receptors (EGF Receptor)IBA 02/2021 - 01/2019
2	Hormones (Hormone)IBA 02/2021 - 01/2019
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2021 - 01/2020
2	pyrotinibIBA 01/2020 - 01/2020
2	osimertinibIBA 10/2019 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 10/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2024
1	AntibodiesIBA 01/2023
1	Heavy MetalsIBA 01/2023
1	nasIBA 01/2022
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2021
1	MAP Kinase Kinase Kinase 1IBA 02/2021
1	Carrier Proteins (Binding Protein)IBA 02/2021
1	Cadherins (E-Cadherin)IBA 02/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2021
1	Myeloid-Lymphoid Leukemia ProteinIBA 02/2021
1	TensinsIBA 02/2021
1	Estrogen Receptor alphaIBA 02/2021
1	LigandsIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	PlatinumIBA 01/2021
1	Phosphotransferases (Kinase)IBA 10/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2020
1	B7-H1 AntigenIBA 06/2020
1	Nuclear Receptor Co-Repressor 1IBA 04/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Estrogen ReceptorsIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Cyclin D1IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 05/2019
1	AndrogensIBA 01/2018
1	Hepatitis B e AntigensIBA 01/2018
1	Sunitinib (Sutent)FDA Link 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 12/2017

Therapy/Procedure

17	Therapeutics 11/2022 - 10/2016
9	Immunotherapy 01/2024 - 01/2017
2	Radiotherapy 10/2023 - 01/2018
2	Neoadjuvant Therapy 08/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 09/2017
1	Chemoradiotherapy 10/2023
1	Cytoreduction Surgical Procedures 01/2021
1	Lasers (Laser) 01/2021
1	Adrenalectomy 12/2017